Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

A longitudinal population-based study of COVID-19 in the UK

In a recent study posted to the medRxiv* pre-print server, researchers identified potential risk factors and incident symptoms of coronavirus disease 2019 (COVID-19) in the general population of the United Kingdom (UK).

21 Jun 2022

Research details patterns of COVID and long COVID symptoms across 42,000 individuals

In a recent study posted to the medRxiv* pre-print server, researchers examined 42,000 participants from nine longitudinal studies conducted in the United Kingdom (UK) to analyze the prevalence of coronavirus disease 2019 (COVID-19) symptoms and characterize long COVID symptom patterns.

21 Jun 2022

Evidence of efficient SARS-CoV-2 transmission between cats

In a recent study posted to the bioRxiv* preprint server, researchers in the Netherlands assessed the indirect and direct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.22 lineage transmission across domestic cats in an experimental environment.

21 Jun 2022

Insufficient drug exposure most likely to cause COVID-19 rebound

Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals.

21 Jun 2022

First open-source program can improve detection and tracking of pathogenic DNA sequences

It's a given that certain bacteria and viruses can cause illness and disease, but the real culprits are the sequences of concern that lie within the genomes of these microbes.

21 Jun 2022

Females are more likely to suffer from Long COVID than males, study reveals

A new study published today in the peer-reviewed journal Current Medical Research and Opinion, reveals that females are "significantly" more likely to suffer from Long COVID than males and will experience substantially different symptoms.

21 Jun 2022

The effect of the COVID-19 BNT162b2 vaccine on semen parameters among semen donors

Researchers explored the impact of COVID-19 BNT162b2 (Pfizer) vaccinations on male fertility among semen donors in Israel.

21 Jun 2022

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Researchers comparatively assessed the generation of B lymphocyte-mediated antibody responses and T lymphocyte-mediated cellular responses between mRNA BNT162b vaccinees and mild COVID-19 patients.

21 Jun 2022

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

A new study reported four cases of Myelin Oligodendrocyte Glycoprotein-Associated Disorder that commenced after SARS-CoV-2 infection.

21 Jun 2022

Study finds traditional African drug inhibits growth of SARS-CoV-2 infection

Researchers evaluated the efficacy of PHELA, a traditional African drug, against SARS-CoV-2 in vitro.

21 Jun 2022

Epidemiological characteristics and transmission dynamics of the Omicron outbreak under lockdown policies in Shanghai

Researchers assessed the epidemiological characteristics of the SARS-CoV-2 Omicron variant outbreak in Shanghai, China.

21 Jun 2022

Infodemiological study on the effect of the COVID-19 pandemic on global headache incidence

Researchers reported the effect of COVID-19 on the global number of headache incidences.

21 Jun 2022

The impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant

Researchers assessed the impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant.

21 Jun 2022

Only 20% of Americans have effective protection against Omicron infection

In a recent research paper published in the Clinical Infectious Diseases journal, scientists analyzed the population immunity against pre-Omicron and Omicron severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) variants in U.S. counties and states up until December 1, 2021. Background

21 Jun 2022

Clonal diversity impacts longevity of T cell reaction specific to SARS-CoV-2 epitope

A recent article under review at the Nature Portfolio journal and currently available on the Research Square* preprint server analyzed the factors influencing the durability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epitope-specific T cell reaction.

21 Jun 2022

After maternal COVID vaccination, infants have persistent anti-SARS-CoV-2 antibodies at 3 months

A recent article published in the journal Clinical Infectious Diseases assessed the kinetics of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies derived from mothers among infants in association with the timing of prenatal SARS-CoV-2 vaccination.

21 Jun 2022

An estimate of Omicron's fitness advantage

Researchers quantify the transmission advantage of the SARS-CoV-2 Omicron variant across forty countries.

21 Jun 2022

How specific comorbidities impact severity of COVID-19

Researchers identify the association between severe COVID-19 and specific comorbidities.

20 Jun 2022

Each SARS-CoV-2 reinfection causes more severe disease

In a recent study under review at the Nature Portfolio journal and currently posted to the Research Square* preprint server, researchers at Washington University School of Medicine and VA Saint Louis Health Care System showed that acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection adds to the risks of all-cause mortality and hospitalization accrued during the first SARS-CoV-2 infection.

20 Jun 2022

Real-world study shows Paxlovid associated with lower hospitalization rates

In a recent study posted to the medRxiv* pre-print server, researchers investigated the effectiveness of nirmatrelvir plus ritonavir in preventing hospitalizations among individuals aged 50 or older and vaccinated for coronavirus disease 2019 (COVID-19).

20 Jun 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

A longitudinal population-based study of COVID-19 in the UK

Research details patterns of COVID and long COVID symptoms across 42,000 individuals

Evidence of efficient SARS-CoV-2 transmission between cats

Insufficient drug exposure most likely to cause COVID-19 rebound

First open-source program can improve detection and tracking of pathogenic DNA sequences

Females are more likely to suffer from Long COVID than males, study reveals

The effect of the COVID-19 BNT162b2 vaccine on semen parameters among semen donors

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

Study finds traditional African drug inhibits growth of SARS-CoV-2 infection

Epidemiological characteristics and transmission dynamics of the Omicron outbreak under lockdown policies in Shanghai

Infodemiological study on the effect of the COVID-19 pandemic on global headache incidence

The impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant

Only 20% of Americans have effective protection against Omicron infection

Clonal diversity impacts longevity of T cell reaction specific to SARS-CoV-2 epitope

After maternal COVID vaccination, infants have persistent anti-SARS-CoV-2 antibodies at 3 months

An estimate of Omicron's fitness advantage

How specific comorbidities impact severity of COVID-19

Each SARS-CoV-2 reinfection causes more severe disease

Real-world study shows Paxlovid associated with lower hospitalization rates

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in